Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current


HC Wainwright & Co. Initiates Coverage On Tyra Biosciences with Buy Rating, Announces Price Target of $12

Author: Benzinga Newsdesk | June 23, 2022 06:08am
HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on Tyra Biosciences (NASDAQ:TYRA) with a Buy rating and announces Price Target of $12.

Posted In: TYRA